A preliminary study was carried out at Johns Hopkins Medicine in Maryland, US
A study has found that up to 30% of patients with wet age-related macular degeneration (AMD) could safely stop eye injections without further vision loss.
Researchers at Johns Hopkins Medicine in Maryland, US carried out a preliminary study of 106 people with wet AMD, which they said did not set a timeline of ending treatment but suggested lifelong treatment may not be needed.
It identified proteins produced at different levels in the eyes of those who stopped therapy, which could lead to the development of a test.
Dr Akrit Sodhi, study lead, said: ‘Such a test could let us tell patients early on how well they would do and when they might be able to stop.’
